focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Distribution Agreement: Food DetectiveT in India

26 Nov 2010 07:00

RNS Number : 8411W
Omega Diagnostics Group PLC
26 November 2010
 



 

Omega Diagnostics Group PLC

("Omega")

Distribution Agreement for Food Detective™ in India

 

Omega, a leading producer of diagnostic testing kits for Food Intolerance announces that its subsidiary, Cambridge Nutritional Sciences Limited, has signed an exclusive distribution agreement with existing marketing partner Thermo Fisher Scientific India Pvt. Ltd. (TFSI) covering the sale and distribution of its Food Detective™ product into the Indian market. The product has recently been approved by the Indian authorities therefore marketing and sale of the product will commence immediately.

 

Mr Andrew Shepherd, CEO of Omega, said: "We're very pleased to announce this deal with TFSI for distribution of Food Detective™ in India which expands our successful business relationship in this strategic market for the company. The product is now being used in over 50 countries and sales for the six months ending 30 September 2010 were £369,000. The Indian Agreement is expected to lead to additional sales of approximately £300,000 over the next three years. This product is well accepted as being a reliable test for those people suffering from the effects of food intolerance. This cost effective test has great potential in the Indian market which will provide a rapid means for more people to realise if their chronic symptoms are food related."

 

Commenting on the distribution agreement, Mr Girish Mehta, Director of TFSI said: "Food Detective™ is a unique product which will address the long unmet demand of identifying food intolerance amongst Indians. This product has been customised for the Indian food diet and has been priced affordably to reach a large population. Thermo Fisher Scientific India with its well-trained and experienced technical and sales teams is well positioned to market Food Detective™ in India and we hope that it will be a big success."

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

Kieron Harbinson, Group Finance Director

www.omegadiagnostics.com

Cenkos Securities plc

Tel: 020 7397 8900

Ian Soanes

Elizabeth Bowman

Walbrook PR Limited

Tel: 020 7933 8787

Paul McManus

Mob: 07980 541 893

 

paul.mcmanus@walbrookpr.com

Paul Cornelius

Tel: 020 7933 8794

 

Mob: 07866 384 707

 

paul.cornelius@walbrookir.com

 

 

 

Information on Omega Diagnostics Group PLC:

Omega sells 86% of production (by turnover) through a network of distributors in over 100 countries. The largest distributor by sales value in the year ending 31 March 2010 was TFSI accounting for approximately 8% of Omega's sales in that financial year.

 

Information on Thermo Fisher Scientific India Pvt. Ltd. /Thermo Fisher Scientific (TFS):

Thermo Fisher Scientific India (TFSI) is the wholly owned subsidiary of Thermo Fisher Scientific USA (TFS) and is a USD 150 million sales organization. TFS is the world wide leader in serving science and offers one-stop-shop solutions to scientific laboratories associated with research, academia, industry, diagnostic testing, quality control, quality assurance etc. TFSI employs over 650 highly qualified and trained personnel to serve the needs of the Indian market and currently offers a wide range of products ranging from state-of-the-art scientific instruments to the smallest of laboratory consumables.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRPGGMUGUPUGMA
Date   Source Headline
6th Sep 20237:00 amRNSAGM Statement
1st Sep 202310:29 amRNSUpdate on proposed Share Reorganisation
31st Aug 20237:00 amRNSProposed Share Reorganisation Timetable
22nd Aug 20237:00 amRNSDirectorate Change
17th Aug 20237:00 amRNSBoard Appointment
15th Aug 20231:45 pmRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSPosting of Annual Report and confirmation of AGM
3rd Aug 20237:00 amRNSFinal Results
27th Jul 20237:00 amRNSNotice of Results
26th Jul 20232:10 pmRNSHolding(s) in Company
6th Jun 202311:19 amRNSHolding(s) in Company
5th Jun 20234:51 pmRNSHolding(s) in Company
2nd Jun 20232:45 pmRNSHolding(s) in Company
22nd May 20235:33 pmRNSHolding(s) in Company
10th May 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th May 20233:42 pmRNSDirector/PDMR Shareholding
21st Apr 20239:48 amRNSHolding(s) in Company
19th Apr 20239:31 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update
22nd Mar 20235:57 pmRNSBlock Listing Six Monthly Return
22nd Mar 20233:00 pmRNSHolding(s) in Company
6th Mar 20232:31 pmRNSHolding(s) in Company
27th Jan 20233:03 pmRNSHolding(s) in Company
27th Jan 20239:36 amRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSTrading update
16th Jan 202310:56 amRNSHolding(s) in Company
6th Jan 20237:00 amRNSUS expansion update
3rd Jan 202312:34 pmRNSHolding(s) in Company
13th Dec 20224:40 pmRNSSecond Price Monitoring Extn
13th Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 202212:01 pmRNSHolding(s) in Company
30th Nov 20229:35 amRNSHolding(s) in Company
25th Nov 20227:00 amRNSReceipt of deferred consideration
24th Nov 20227:00 amRNSHalf-year Report
23rd Nov 20224:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20222:05 pmRNSSecond Price Monitoring Extn
23rd Nov 20222:00 pmRNSPrice Monitoring Extension
18th Nov 202212:09 pmRNSHolding(s) in Company
16th Nov 20222:06 pmRNSSecond Price Monitoring Extn
16th Nov 20222:00 pmRNSPrice Monitoring Extension
15th Nov 20227:00 amRNSConfirmation of Results and Investor Presentation
14th Nov 20227:00 amRNSPartnership agreement with Software Provider
8th Nov 20229:04 amRNSLaunch of new all-employee share incentive plan
26th Oct 20222:50 pmRNSResult of AGM
26th Oct 20227:00 amRNSAGM Statement and Notice of Results
11th Oct 20227:00 amRNSScientific Director to present at FIDHC
5th Oct 20227:00 amRNSPositive WHO data received for VISITECT® CD4 test
27th Sep 20227:00 amRNSPosting of Annual Report and confirmation of AGM
20th Sep 202212:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.